Office for Life Sciences Bulletin – 09 April 2021
OLS Introduction The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS). This bulletin aims to keep the life sciences sector up to date on the latest guidance and during the Coronavirus (COVID-19) outbreak, providing you with information from Government to help your members and networks prepare. If you would like to be added to the distribution list, please email nita.bhanot@beis.gov.uk For any questions on the UK/EU Trade and Cooperation Agreement, please contact euexit@officeforlifesciences.gov.uk
News NEW – The Medicines and Diagnostics Manufacturing Transformation Fund is now open. The fund aims to boost economic opportunities, innovation and health resilience by supporting medicines and diagnostics manufacturing investments in the UK. Applicants are invited to apply for a share of the total fund of £20m. Application portal closes 30th June 2021. For more information and to apply, click here. NEW – From Monday 12th April England will move to Step Two of the roadmap. Some of the rules on what you can and cannot do will change on 12 April. For more information on how COVID-19 restrictions will be eased in England, view the roadmap here. NEW – The Recovery Loan Scheme was launched on Tuesday 6 April by the Chancellor of the Exchequer to provide additional finance to those businesses that need it. Businesses can access loans varying in size from £25,000, up to a maximum of £10 million. Invoice and asset finance is available from £1,000. The Chancellor of the Exchequer’s statement is here. For more information on what other financial support you can get for your business, click here. NEW – DHSC Chief Commercial Officer Steve Oldfield has written an open letter to medicines and medical product suppliers covering continuity of supply, new import controls and batch testing. To view this letter, click here.